1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow David Marcinek: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Healthy Aging and Physical Function With Elamipretide Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol) - Aging, Healthy | Phase 2 | Recruiting | David Marcinek | 30 | 2025-11-26 | 2025-12-10 |
Benzyl Alcohol (1) · arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1)
United States (1)